Desk›Healthcare› AstraZeneca Pharma India Ltd
AstraZeneca Pharma India Ltd
BSE 506820 · NSE ASTRAZEN · ISIN INE203A01020 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹7,121.10
-0.48%
BSE close, 28 August 2026
₹17,802.75 cr
2.5 cr shares · Small cap
₹4,385.46 cr
as published
105.0× · 26.21×
EPS ₹67.85 · BV ₹271.69
2,275.58 / 187.52
₹ cr, as filed
19
5 selected · 26%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -27.7% |
|---|---|
| Against 52-week low | +0.7% |
| Day change | -0.48% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹67.85 |
|---|---|
| Price / earnings | 104.95× |
| Price / book | 26.21× |
| Book value — derived, price ÷ P/B | ₹271.69 |
| Return on equity | 24.97% |
| Operating margin | 8.48% |
| Net margin | 5.56% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 24.97%
- ROE as published
- 24.97%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 682.79 | 37.93 | 15.17 | 8.48% | 5.56% |
| Mar-26 · Q | 578.61 | 44.88 | 17.95 | 11.37% | 7.76% |
| FY25-26 | 2,275.58 | 187.52 | 75.01 | 12.54% | 8.24% |
Quarter on quarter
- Revenue, quarter on quarter
- +18.0%
- Net profit, quarter on quarter
- -15.5%
- Operating margin, quarter on quarter
- -289 bps
Disclosure profile 19 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Order / Contract | 2 |
| KMP | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| General | 7 |
| AGM / EGM | 2 |
| Analyst / Investor Meet | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 14 |
| Total | 19 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
19 filings · 5 selected · busiest 2026-07-28 and 2026-08-10
Filing rhythm · the twelve most recent
2026-08-042026-09-18
SelectedProcedural
Filings
19 in the window · 8 earlier on record
-
18 September 2026 ·
Award_of_Order_Receipt_of_Order
Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.
Company Update / Award of Order / Receipt of Order View filing →
-
15 September 2026 ·
Closure of Trading Window
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Insider Trading / SAST / Closure of Trading Window View filing →
-
15 September 2026 ·
Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Senior Management Personnel
Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.
Company Update / General View filing →
-
2 September 2026 ·
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG Rating
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Company Update / General View filing →
-
25 August 2026 ·
Award_of_Order_Receipt_of_Order
Please find the enclosed document of the Company in relation to the captioned subject for your reference.
Company Update / Award of Order / Receipt of Order View filing →
-
24 August 2026 ·
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG Rating
Please find the enclosed intimation of the Company in relation to the captioned subject for reference.
Company Update / General View filing →
-
21 August 2026 ·
Analyst / Investor Meet - Intimation
Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.
Company Update / Analyst / Investor Meet View filing →
-
12 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Press Release / Media Release
Please find the enclosed Press Release of the Company for your reference.
Company Update / Press Release / Media Release View filing →
-
10 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
AGM/EGM / AGM View filing →
-
10 August 2026 ·
Outcome Of The Board Meeting Held On Monday, August 10, 2026
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Result / Financial Results View filing →
-
4 August 2026 ·
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday, August 10, 2026
Astrazeneca Pharma India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve This is to inform ....
Board Meeting / Board Meeting View filing →
-
30 July 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find the enclosed document of the Company in relation to the captioned subject for your reference.
Company Update / General View filing →
-
29 July 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
28 July 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Company Update / General View filing →
-
28 July 2026 ·
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
Please find the enclosed letter of the Company as per the captioned subject for your reference.
Company Update / General View filing →
-
22 July 2026 ·
Communication To The Shareholders W.R.T. TDS On Dividend
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Company Update / General View filing →
-
21 July 2026 ·
Resignation of Chief Financial Officer (CFO)
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Company Update / Resignation of Chief Financial Officer (CFO) View filing →
-
20 July 2026 ·
Newspaper Publication
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Company Update / Newspaper Publication View filing →
RSS feed for AstraZeneca Pharma India Ltd · the 50 most recent filings